This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van der Auwera, P
Right arrow Articles by Scorneaux, B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van der Auwera, P
Right arrow Articles by Scorneaux, B

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1985 July; 28(1): 37-40

In vitro susceptibility of Campylobacter jejuni to 27 antimicrobial agents and various combinations of beta-lactams with clavulanic acid or sulbactam.

P Van der Auwera and B Scorneaux

ABSTRACT

The in vitro susceptibility of human isolates of Campylobacter jejuni was investigated with 27 antibiotics and 8 combinations of beta-lactams with clavulanic acid or sulbactam. Ansamycin, the new quinolines, erythromycin, and cefpirome were the most active drugs against C. jejuni; amoxicillin, ampicillin, cefotaxime, and ceftazidime 90% of the isolates, greater than or equal to 50 mg/liter). The activity of various beta-lactams was unchanged by the addition of clavulanic acid or sulbactam.


Antimicrob Agents Chemother. 1985 July; 28(1): 37-40




This article has been cited by other articles:

  • WOLFSON, J. S., HOOPER, D. C. (1988). Norfloxacin: A New Targeted Fluoroquinolone Antimicrobial Agent. ANN INTERN MED 108: 238-251 [Abstract]  
  • ERICSSON, C. D., JOHNSON, P. C., DUPONT, H. L., MORGAN, D. R., BITSURA, J. A. M., JAVIER DE LA CABADA, F. (1987). Ciprofloxacin or Trimethoprim-Sulfamethoxazole as Initial Therapy for Travelers' Diarrhea: A Placebo-Controlled, Randomized Trial. ANN INTERN MED 106: 216-220 [Abstract]